Combining LC–MS/MS and Hollow-Fiber Infection Model For Real-Time Quantitation of Ampicillin to Antimicrobial Resistance

Adarsh Gandhi1 Division of Applied Regulatory Science, Office of Clinical Pharmacology, Food & Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD20993, USACorrespondence[email protected]

Murali Matta1 Division of Applied Regulatory Science, Office of Clinical Pharmacology, Food & Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD20993, USA

Tesfalem Zere1 Division of Applied Regulatory Science, Office of Clinical Pharmacology, Food & Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD20993, USA

James Weaver1 Division of Applied Regulatory Science, Office of Clinical Pharmacology, Food & Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD20993, USA

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Combining LC–MS/MS and Hollow-Fiber Infection Model For Real-Time Quantitation of Ampicillin to Antimicrobial Resistance

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combining LC–MS/MS and Hollow-Fiber Infection Model For Real-Time Quantitation of Ampicillin to Antimicrobial Resistance

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date